| abstract |
Provided is a novel protein that exhibits neuraminidase activity and/or β-galactoside-α2,6-sialyltransferase activity. Also provided are a nucleic acid that codes for said protein, a vector containing a nucleic acid that codes for said protein, a host cell transformed by said vector, a method for producing recombinant β-galactoside-α2,6-sialyltransferase, and an antibody that specifically recognizes the aforementioned protein. |